MedTrace Logo

Perianal Fistula Treatment With Autologous Adipose Tissue Injection

NCT03913910 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2019-05-14

No results posted yet for this study

Summary

The study aims to evaluate the efficacy of the local injection of autologous micro-fragmented adipose tissue obtained with the Lipogems®system in patients with trans-sphincteric fistulas untreatable with fistulotomy.

Conditions

  • Perianal Fistula

Interventions

PROCEDURE

Lipogems

Autologous micro-fragmented adipose tissue is injected in the internal orifice, mucosal, submucosal and muscular layer, then in the fistula tract and external orifice in addition to anal flap.

Sponsors & Collaborators

  • Azienda Ospedaliero, Universitaria Pisana

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-02-01
Primary Completion
2019-12-31
Completion
2020-06-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03913910 on ClinicalTrials.gov